Schaumburg, Illinois – Bimeda is excited to announce the expansion of its anti-parasitic portfolio with the introduction of MoxiSolv Injection (moxidectin). MoxiSolv stands out as the only FDA-approve...
Bimeda is pleased to announce the appointment of Casey Story as Senior Territory Manager. Casey will be an integral part of US Cattle Sales team in the states of Kentucky, Tennessee, Mississippi, Alab...
Bimeda is pleased to announce the appointment of Colby Flatt as Senior Territory Manager for the region of Southern Missouri, Eastern Oklahoma and Arkansas. Colby will be an integral part of the US Ca...
Schaumburg, Illinois – Bimeda, Inc. has recently launched Bimasone, the first generic flumethasone for certain diseases that cause inflammation in horses, dogs and cats including rheumatic, aller...
Effective immediately, Ron is serving a newly created role of National Sales Director-Cattle as Bimeda expands their US Cattle Sales footprint.Ron grew up in animal agriculture and has been a par...
Oakbrook Terrace, Illinois (January 25, 2024) – Bimeda, Inc. has recently launched BOVitalize™ in the US. BOVitalize is an oral vitamin and mineral supplement for beef and dairy cows, bulls and rumina...
Bimeda Holdings Chairman, Donal Tierney, Minister for Enterprise, Trade and Employment, Simon Coveney TD, and Professor Helen Roche, interim UCD Vice-President for Research, Innovation and Impact toda...
Oakbrook Terrace, Illinois (July 19, 2023) – Bimeda Inc. is pleased to announce that SpectoGard (spectinomycin sulfate) Sterile Solution—which received FDA approval in September of 2022—is now availab...
Bimeda is pleased to announce the appointment of Jim Lovin as a Strategic Accounts Manager - Swine. Jim will focus on the development and management of both core Bimeda products and custom vaccine lin...
Bimeda Biologicals® is pleased to announce the newest addition to their Stimulator® line of modified live virus (MLV) vaccines: Stimulator® 5 + PMH. With this launch, Bimeda Biologicals adds to their ...
Bimeda® Inc. is thrilled to announce their new partnership with The Spirit of Hagyard podcast. Created in 2022, the podcast was developed by Hagyard Equine Medical Institute, a renowned equine veterin...
Bimeda is pleased to announce the launch of the company's first Annual Sustainability Report. The report is now available to read and download on onebimeda.com In early 2022, Bimeda announced the laun...
Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...
Bimeda is pleased to announce the launch of a new sustainability-focused website, onebimeda.com. The website details Bimeda's sustainability mission statement and the five Sustainability Pillars which...
Bimeda is pleased to announce the appointment of Samuel Cossio as Territory Sales Manager for the states of Idaho, Oregon, and Washington. Sam will be part of the livestock sales team and assist in th...
Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...
Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...
Bimeda® Inc. announced the launch of Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings, to veterinarians. Th...
It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the...
Dear Customers, Distributors and Retailers, Bimeda received communication from the Food and Drug Administration's (FDA) Center for Veterinary Medicine (CVM) regarding continued concerns that people ar...